Download
1 / 19
190 likes | 251 Views
Global Biosimilars market is estimated to reach $46.0 Billion by 2025; growing at a CAGR of 33% from 2017 to 2025. Biosimilars are the biotechnological product that is proved to be comparable to an already approved reference product in quality, nonâ€clinical and clinical evaluation.
E N D
Global Biosimilars Market is estimated to reach $46.0 Billion by 2025, Says Variant Market Research Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com Bhavana Patel Seo Analyst help@variantmarketresearch.com
Biosimilars Market • Global Biosimilars marketis estimated to reach $46.0 Billion by 2025; growing at a CAGR of 33% from 2017 to 2025. Biosimilars are the biotechnological product that is proved to be comparable to an already approved reference product in quality, non‐clinical and clinical evaluation. The generic equivalents of biologics are meant as a ‘biosimilars’. A biosimilar is a highly similar, comparable version of an approved biologic medicine, which undergo through clinical trials to demonstrate that it works just as the approved biologic medicine. It is used to treat a wide range of conditions including cancer and autoimmune diseases. Regulatory guidelines for biosimilar development and approval are rigorous and undergoing constant refinement. Biosimilars offer good alternate treatment options in patients who cannot be treated with synthetic DMARDs (Disease-modifying antirheumatic drugs). • Download Free Sample Copy of Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/biosimilars-market/sample-request Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Global Biosimilars Market Size and Forecast, 2016 - 2025 Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Biosimilars Market • Product, manufacturing type, disease and geography are the segment of biosimilars market. The product segment is categorized into recombinant non-glycosylated proteins (insulin, interferon, recombinant human growth hormone, and granulocyte colony-stimulating factor), recombinant glycosylated proteins (erythropoietin, follitropin, and monoclonal antibodies), and recombinant peptides (glucagon, and calcitonin). In-house manufacturing and contract manufacturing are the bifurcations of manufacturing type. Furthermore, oncology, chronic diseases, growth hormone deficiency, blood disorders, infectious diseases, autoimmune diseases, and other diseases are segregated under disease segment. • Browse the Complete Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/biosimilars-market Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Global Biosimilars Market, by Manufacturing Type Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Top Key Players • Celltrion Inc. • Biocon • Hospira Inc. • Merck KGaA • Biogen • Genentech, Inc. • LG Life Sciences • Novartis AG • Synthon, and Teva Pharmaceutical Industries Ltd., among others. Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Global Biosimilars Market Regional Revenue Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
The key takeaways from the report • The report will provide detailed analysis of Global Biosimilars Market with respect to major segments such as product, manufacturing type, disease and geography • The report will include the qualitative and quantitative analysis with market estimation over 2016 – 2025 and compound annual growth rate (CAGR) between 2017 and 2025 • Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report • An exhaustive regional analysis of Global Biosimilars Market has been included in the report • Profile of the key players in the Global Biosimilars Market will be provided, which include key financials, product & services, new developments and business strategies Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Global Biosimilars Market Primary Interviews, by Geography Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Scope of the Global Biosimilars Market Product Segments • Recombinant Non-Glycosylated Proteins • Insulin • Interferon • Recombinant Human Growth Hormone • Granulocyte Colony-Stimulating Factor • Recombinant Glycosylated Proteins • Erythropoietin • Follitropin • Monoclonal Antibodies Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Scope of the Global Biosimilars Market Product Segments • Recombinant Peptides • Glucagon • Calcitonin Manufacturing Type Segments • In-House Manufacturing • Contract Manufacturing Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Scope of the Global Biosimilars Market Disease Segments • Oncology • Chronic Diseases • Growth Hormone Deficiency • Blood Disorders • Infectious Diseases • Autoimmune Diseases • Other Diseases Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Scope of the Global Biosimilars Market Geographical Segments • North America • U.S. • Canada • Mexico • Europe • UK • Germany • France • Italy • Rest of Europe Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Scope of the Global Biosimilars Market Geographical Segments • Asia-Pacific • India • China • Japan • South Korea • Rest of Asia-Pacific • RoW • South America • Middle East • Africa Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Table of Content Chapter 1 Prefix 1.1 Market Scope 1.2 Report Description 1.3 Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 In-house Data Modeling Chapter 2 Executive Summary 2.1 Global Biosimilars Market Year-on-Year Growth, 2017 – 2025 (%) Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Table of Content Chapter 3 Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Market Dynamics 3.3.1 Drivers 3.3.1.1 Impact Analysis 3.3.2 Restraints 3.3.2.1 Impact Analysis 3.3.3 Opportunities ..... Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Table of Content Chapter 8 Company Profiles 8.1 Celltrion Inc. 8.2 Biocon 8.3 Merck KGaA 8.4 BIOGEN 8.5 Genentech, Inc. 8.6 LG LIFE SCIENCES 8.7 Novartis AG 8.8 Synthon 8.9 Teva Pharmaceutical Industries Ltd. 8.10 Hospira Inc. Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Contact Us John Dave, Head - Sales Variant Market Research 649 Mission St, 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: john.dave@variantmarketresearch.com Email: help@variantmarketresearch.com Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
Thank-You….. Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
